The Clorox Company - FY 2027 First Quarter Earnings - CLOROX CO

Financial Performance:

• Fiscal Year 2027 Q1 delivered better-than-expected results driven by strong execution and favorable timing benefits.
• Full-year input cost inflation guidance increased to $240 million ($40 million higher than年初), approximately 2.5x the historical annual average, driven by broad commodity inflation, supply chain, and transportation costs.
• Full-year organic sales growth guidance remains 3.5% to 4.5% (including ~3.5 points from lapping the ERP transition); organic sales excluding ERP lapping are expected to be flat to +1%.
• Cost savings in Q1 were among the highest on record, driven by a strengthened productivity engine, RGM, and design-to-value capabilities.
• Gross margins are expected to compress on average for the full year but are projected to exit significantly stronger in the back half due to the phasing of mitigation actions and cost savings.
• SG&A guidance was slightly adjusted from 16% to 15%, influenced by acceleration of Gojo synergies and one-time items; Q1 benefited from favorable tax rates due to early international restructuring.
• The Gojo acquisition is showing earlier-than-expected synergy realization, with line of sight to the full $50 million cost synergy target in Year 1.

Guidance and Future Outlook:

• Q2 organic sales are guided to be flat to -2%, influenced by shipment comparisons, merchandising timing, and ERP lapping dynamics.
• Full-year organic sales growth excluding ERP impacts is projected to improve from slightly down in the first half to slightly up in the second half.
• Management anticipates inflationary pressures to be more pronounced in the first half, with mitigation actions ramping up in the second half.
• Long-term margin targets remain at 43-44% gross margin and ~18% operating margin; current productivity gains and Gojo synergies position the company to reach these targets.
• The company expects to see better market share performance in the back half as execution improves and innovation launches peak.
• Innovation pipeline for the back half is described as one of the strongest on record, with significant product improvements scheduled for release.

Business Segments and Product Lines:

• Home Care: Gained >0.5 share points; driven by innovation, successful Back-to-School merchandising, and broad-based promotion strength.
• Brita: Experienced strong share growth correlated with Back-to-School/College merchandising.
• Hidden Valley: Grew nearly 2 share points despite category pressure from a Cyclospora outbreak; outperformed as a condiment with diverse usage occasions.
• Litter (Cat Litter): Margin profile below 30%; the segment is making "green shoots" in market share but remains a drag on overall performance; includes targeted pricing investments to improve value proposition.
• Glad: Heavily impacted by resin costs; implemented high-single-digit price increase in July to offset inflation; volume impact remains in line with expectations.
• Kingsford: Delivered high-single-digit growth and share gains during Labor Day, indicating improved execution for the holiday season.
• Health & Wellness: Delivered strong price mix (+7%), with ~6 points attributable to Gojo and ~1 point from base business RGM and targeted pricing.

Market and Competitive Landscape:

• Consumer behavior continues to show value-seeking trends (stocking up, smaller sizes, delayed purchases), though some timing shifts (e.g., Back-to-School) have been managed successfully.
• Competitive activity and retailer behavior remain broadly in line with company expectations for the year.
• The company is navigating a volatile commodity environment with broader inflation extending beyond energy costs into raw materials and logistics.
• Market share improvements are being driven by "superiority" (innovation, quality) and operational excellence rather than just price wars.

Risks and Challenges:

• Persistent and volatile input cost inflation (commodities, transportation) remains a primary headwind.
• The Litter category continues to struggle with share and margin recovery due to competitive pricing and the need for strategic investments.
• Execution risks associated with the ongoing ERP transition, though the company states the "noise" is behind them.
• Consumer economic stress and value-seeking behavior could limit volume growth in the short term.

Management Commentary and Tone:

• CEO Linda Rundle expressed confidence in the business trajectory, emphasizing a transition from investment to optimization and value creation.
• Rundle announced the appointment of Fabian Garcia as the next CEO, effective January, describing him as a disciplined executor with a strong background in brand building and innovation.
• Tone was resilient and optimistic about the second half, citing a stronger productivity engine, effective pricing tools, and a robust innovation pipeline.
• Management emphasized a balanced approach to margin recovery, prioritizing market share protection while utilizing RGM, cost savings, and targeted pricing.
• The transition of leadership was described as smooth and seamless, with Rundle remaining fully focused through January.

Analyst Questions and Answers:

• Commodity Phasing: Peter Grom (UBS) asked about cost phasing; management confirmed front-half pressure with mitigation stacking in the back half.
• Mitigation Strategy: Anna (Bank of America) inquired on cost savings vs. pricing; management noted productivity and cost savings are the primary margin recovery drivers, with pricing playing a targeted role.
• Share Growth Sources: Robert Moscow (TD Cowen) asked for segment details; Rundle highlighted Home Care, Brita, Hidden Valley, and Kingsford as key gainers.
• Innovation & Pricing Timing: Andrea Teixeira (JP Morgan) asked about the balance of pricing and innovation; management confirmed pricing will be timed with innovation launches in the back half to support superiority.
• Long-term Margins: Kevin Grundy (BNP Paribas) asked about long-term margin targets; management reiterated 44-45% gross and 18% operating margins as the North Star.
• SG&A Changes: Chris Carey (Wells Fargo) asked about the SG&A outlook change; management attributed the shift to Gojo synergy acceleration and timing of one-time items.
• Cost Savings Sustainability: Javier Escalante (Evercore ISI) questioned the drivers of record cost savings; management cited a stronger productivity engine (tech/data capabilities) and the ramp-up of ERP benefits.
• Gojo Contribution: Olivia Tong (Raymond James) asked about price mix drivers in Health & Wellness; confirmed Gojo contributed the majority of the favorable mix.

Other Key Points:

• Fabian Garcia will officially start as CEO on January 1st; the transition is underway with regular communication between the outgoing and incoming CEO.
• The company's advertising spend is elevated at approximately 12% of US retail sales (higher than the historical 10% average), reflecting a commitment to brand building and superiority.
• Cost visibility is generally 2-3 months out; the company uses a mix of financial hedges and contractual agreements to manage volatility.
• The ERP transition has moved from implementation/stabilization to a value creation phase, expected to reduce cost complexity over the next few years.
• The company is actively optimizing trade funds using new technology tools to improve ROI.